Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 1
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2241)
- Volume 19, 2023 (24)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 2, 2006

Transdermal buprenorphine in the management of persistent pain – safety aspects
Rudolf Likar
Therapeutics and Clinical Risk Management 2006, 2:115-125
Published Date: 15 March 2006

Percutaneous dermal drug delivery for local pain control
Sujatha Tadicherla, Brian Berman
Therapeutics and Clinical Risk Management 2006, 2:99-113
Published Date: 15 March 2006

Renal cell carcinoma and the use of sorafenib
James MG Larkin, Tim Eisen
Therapeutics and Clinical Risk Management 2006, 2:87-98
Published Date: 15 March 2006

Differences between the bisphosphonates for the prevention and treatment of osteoporosis
Andrew Grey, Ian R Reid
Therapeutics and Clinical Risk Management 2006, 2:77-86
Published Date: 15 March 2006

Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia
George G Zhanel, Tamiko Hisanaga, Aleksandra Wierzbowski, Daryl J Hoban
Therapeutics and Clinical Risk Management 2006, 2:59-75
Published Date: 15 March 2006

Etoricoxib for arthritis and pain management
Peter Brooks, Paul Kubler
Therapeutics and Clinical Risk Management 2006, 2:45-57
Published Date: 15 March 2006

Anti-hepatitis C virus therapy in liver transplanted patients
Antonino Picciotto
Therapeutics and Clinical Risk Management 2006, 2:39-44
Published Date: 15 March 2006

Ciclesonide for the treatment of asthma
Ronald Dahl
Therapeutics and Clinical Risk Management 2006, 2:25-37
Published Date: 15 March 2006

Oxybutynin: an overview of the available formulations
Rebecca J McCrery, Rodney A Appell
Therapeutics and Clinical Risk Management 2006, 2:19-24
Published Date: 15 March 2006

Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
Frieder Bauss and Ralph C Schimmer
Therapeutics and Clinical Risk Management 2006, 2:3-18
Published Date: 15 March 2006

Editorial ||FREE PAPER||
Garry Walsh
Therapeutics and Clinical Risk Management 2006, 2:1-2
Published Date: 15 March 2006